Quality Measures
With Enterprise Chart enabled, if the following Quality measures require an action not associated with an encounter, NextGen® HQM looks across the enterprise to see if that action has occurred.
| Measure Number | Measure Title |
|---|---|
| 1 | Diabetes: Hemoglobin A1c Poor Control |
| 5 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| 6 | Coronary Artery Disease (CAD): Antiplatelet Therapy |
| 7 | Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) |
| 8 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| 12 | Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation |
| 14 | Age-Related Macular Degeneration (AMD): Dilated Macular Examination |
| 19 | Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care |
| 39 | Screening for Osteoporosis for Women Aged 65-85 Years of Age |
| 47 | Care Plan |
| 48 | Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older |
| 50 | Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older |
| 51 | Chronic Obstructive Pulmonary Disease (COPD): Spirometry |
| 52 | Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy |
| 68 | Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy |
| 110 | Preventive Care and Screening: Influenza Immunization |
| 111 | Pneumonia Vaccination Status for Older Adults |
| 112 | Breast Cancer Screening |
| 113 | Colorectal Cancer Screening |
| 117 | Diabetes: Eye Exam |
| 118 | Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) |
| 119 | Diabetes: Medical Attention for Nephropathy |
| 122 | Adult Kidney Disease: Blood Pressure Management |
| 126 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation |
| 127 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear |
| 137 | Melanoma: Continuity of Care – Recall System |
| 140 | Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement |
| 141 | Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care |
| 154 | Falls: Risk Assessment |
| 155 | Falls: Plan of Care |
| 178 | Rheumatoid Arthritis (RA): Functional Status Assessment |
| 204 | Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
| 205 | HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis |
| 224 | Melanoma: Overutilization of Imaging Studies in Melanoma |
| 226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
| 236 | Controlling High Blood Pressure |
| 238 | Use of High-Risk Medications in the Elderly |
| 243 | Cardiac Rehabilitation Patient Referral from an Outpatient Setting |
| 268 | Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy |
| 271 | Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury – Bone Loss Assessment |
| 282 | Dementia: Functional Status Assessment |
| 291 | Parkinson’s Disease: Cognitive Impairment or Dysfunction Assessment |
| 320 | Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients |
| 326 | Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy |
| 336 | Maternity Care: Post-Partum Follow-Up and Care Coordination |
| 370 | Depression Remission at Twelve Months |
| 386 | Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences |
| 390 | Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment Options |
| 394 | Immunizations for Adolescents |
| 398 | Optimal Asthma Control |
| 400 | One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk |
| 401 | Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis |
| 402 | Tobacco Use and Help with Quitting Among Adolescents |
| 403 | Adult Kidney Disease: Referral to Hospice |
| 410 | Psoriasis: Clinical Response to Oral Systemic or Biologic Medications |
| 411 | Depression Remission at Six Months |
| 412 | Documentation of Signed Opioid Treatment Agreement |
| 435 | Quality Of Life Assessment For Patients With Primary Headache Disorders |
| 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
| 444 | Medication Management for People with Asthma (MMA) |